Formulation of extended release cefpodoxime proxetil chitosan-alginate beads using quality by design approach

International Journal of Biological Macromolecules

Volumn 69, Issue , 2014, Pages 420-429

  Mujtaba, Ali ^a   Ali, Mushir ^a   Kohli, Kanchan ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Box Behnken design; Cefpodoxime proxetil; Quality by design

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; CEFPODOXIME PROXETIL; CHITOSAN; ANTIINFECTIVE AGENT; CEFTIZOXIME; DELAYED RELEASE FORMULATION; GLUCURONIC ACID; HEXURONIC ACID; MICROSPHERE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG QUALITY; ENCAPSULATION; ESCHERICHIA COLI; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; TIMED DRUG RELEASE; X RAY DIFFRACTION; ANALOGS AND DERIVATIVES; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; KINETICS; MEDICINAL CHEMISTRY; PROCEDURES;

ALGINATES; ANTI-INFECTIVE AGENTS; CALCIUM CHLORIDE; CEFTIZOXIME; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; ESCHERICHIA COLI; GLUCURONIC ACID; HEXURONIC ACIDS; KINETICS; MICROSPHERES; PARTICLE SIZE; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 84902578115     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.05.066     Document Type: Article

References (34)

1. Wu H., White M., Khan M.A. Int. J. Pharm. 2011, 405:63-78.
2. ICH Guidance for Industry Q8 Pharmaceutical Development, Current Step 4 2006, August 2009.
3. FDA Guidance For Industry, PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance 2004, Center for Drug Evaluation and Research (CDER), Rockville, MD, USA.
4. Singh B., Mehta G., Kumar R., Bhatia A., Ahuja N., Katare O.P. Curr. Drug Deliv. 2005, 2:143-153.
5. Montgomery D.C. Design and Analysis of Experiments 1991, John Wiley & Sons. Inc., Somerset, NJ, USA. 3rd ed.
6. Govender S., Pillay V., Chetty D.J., et al. Int. J. Pharm. 2005, 306:24-40.
7. Zidan A.S., Sammour O.A., Hammad M.A., et al. Int. J. Pharm. 2007, 332:55-63.
8. Tønnesen H.H., Karlsen J. Drug Dev. Ind. Pharm. 2002, 28:621-630.
9. Hejazi R., Amiji M. J. Control. Release 2003, 89:151-165.
10. Wittaya-Areekul S., Kruenate J., Prahsarn C. Int. J. Pharm. 2006, 312:113-118.
11. Bajpai S.K., Sharma S. React. Funct. Polym. 2004, 59:129-140.
12. Griffith L.G. Acta Mater. 2000, 48:263-277.
13. Lin Y.H., Liang H.F., Chung C.K., Chen M.C., Sung H.W. Biomaterials 2005, 26:2105-2113.
14. Zhang H., Alsarra I.A., Neau S.H. Int. J. Pharm. 2002, 239:197-205.
15. Borin M.T. Drugs 1991, 42:13-21.
16. Saathoff N., Lode H., Neider K., Depperman K.M., Borner K., Koeppe P. Antimicrob. Agents Chemother. 1992, 36:796-800.
17. Anal A.K., Bhopatkar D., Tokura S., Tamura H., Stevens W.F. Drug Dev. Ind. Pharm. 2003, 29:713-724.
18. Candioti L.V., Robles J.C., Mantovani V.E., Goicoechea H.C. Talanta 2006, 69:140-147.
19. Box G.E.P., Behnken D.W. Technometrics 1960, 2:455-475.
20. Anal A.K., Stevens W.F. Int. J. Pharm. 2005, 290(1-2):45-54.
21. Kim M.S., Kim J.S., You Y.H., Park H.J., Lee S., Park J.S., Woo J.S., Hwang S.J. Int. J. Pharm. 2007, 341:97-104.
22. Lee J.W., Kim S.Y., Kim S.S., Lee Y.M., Lee K.M., Kim S.J. J. Appl. Polym. Sci. 1999, 73:113-120.
23. Bourgeois S., Gernet M., Pradeau D., Andremont A., Fattal E. Int. J. Pharm. 2006, 324:2-9.
24. Segurola J., Allen N.S., Edge M., McMahon A. Prog. Org. Coat. 1999, 37:23-37.
25. Douglas K.L., Tabriziani M. J. Biomater. Sci. Polym. Ed. 2005, 16:43-56.
26. Rajinikanth P.S., Sankar C., Mishra B. Drug Deliv. 2003, 10:21-28.
27. Sezer A.D., Akbuga J. J. Microencapsul. 1999, 16:195-203.
28. Myers R.H., Montgomery D.C. Response Surface Methodology: Process and Product Optimization using Designed Experiments 2002, 273-286. John Wiley & Sons, New York.
29. Siepmann J., Peppas N. Adv. Drug Deliv. Rev. 2001, 48:139-157.
30. Ritger P.L., Peppas N. J. Control. Release 1987, 5:37-42.
31. Pasparakis G., Bouropolous N. Int. J. Pharm. 2006, 323:34-42.
32. Mujtaba A., Ali M., Kohli K. Adv. Sci. Eng. Med. 2013, 5:950-956.
33. Mujtaba A., Ali M., Kohli K. Chem. Eng. Res. Des. 2014, 92:156-165.
34. Chu J., Li G., Row K.H., Kim H., Lee Y.W. Int. J. Pharm. 2009, 18:85-91.